Blog
18 December 2018
6 tests for assessing cognition in Parkinson’s disease
Cognitive dysfunction in Parkinson’s disease remains a significant, unmet therapeutic need for patients; as such it is vital that there is rigorous research into the topic. Here we will discuss six CANTAB tasks that can address this research gap.
Read on
5 December 2018
Normative data from linear and non-linear quantile regression in CANTAB: cognition in mid-to-late life in an epidemiological sample
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring recently published the first study to derive normative CANTAB data from quantile regressions of cognitive test performance for a large epidemiological sample of adults aged 57-84 years.
Read on
7 November 2018
Emotion recognition biases in alcohol use disorder
Researcher at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), Clara Freeman, shared with us about why she chose the CANTAB Emotion Recognition Task for her latest publication.
Read on
1 November 2018
Why is it important to assess cognition in criminal cases?
Dr Seán Haldane is a Consultant Neuropsychologist and expert witness who provides reports for defence lawyers, the Crown Prosecution Service and the police. We caught up with Dr Haldane to discuss how CANTAB Insight is integral to his work.
Read on
25 October 2018
CANTAB tests predict functional decline in patients with amnestic mild cognitive impairment
We presented a novel, predictive model of functional decline at CTAD 2018. The model suggests that CANTAB PAL and SWM provide essential screening information when recruiting patients with amnestic mild cognitive impairment into Alzheimer’s disease clinical trials.
Read on
24 October 2018
Using Bayesian methods to model normative CANTAB cognitive performance across adulthood
At CTAD 2018 we shared our new data on why a Bayesian approach is best to describe normative cognitive performance, especially when making scientifically robust comparisons to neurologically impaired groups.
